Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201209125 Principal Investigator: Tran, David
Title: A Phase II Study of Rindopepimut/GM-CSF in Patients with Relapsed EGFRvIII-Positive Glioblastoma (CDX110-06)
Phase: II Disease Site: Brain & Nervous System
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out whether adding rindopepimut and GM-CSF to bevacizumab helps to shrink brain tumors, prevent brain tumors from growing, or help patients with brain tumors live longer than treatment with bevacizumab alone.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)